The purpose of this policy is to identify and manage conflicts of interest of Institutional Biosafety Committee (IBC) members and consultants that may affect or appear to affect their contributions to protocol review, DURC reviews, or actions to suspend or revoke authorization for previously approved research.
Except when providing information at the IBC’s request, no IBC member or consultant with a conflict of interest with respect to research may be involved in the review or approval of such research, or in deliberations or voting on actions to suspend, revoke or reinstate authorization for such research. An IBC member may not be counted for quorum in an IBC vote regarding such research.
10-05-2016, 03-07-2018